Comparison of the mutational spectra of the lacZ transgene in four organs of the Muta™Mouse treated with benzo[a]pyrene: target organ specificity

Gossen, 1989, Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo, Proc. Natl. Acad. Sci. U. S. A., 86, 7971, 10.1073/pnas.86.20.7971 Kohler, 1991, Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice, Proc. Natl. Acad. Sci. U. S. A., 88, 7958, 10.1073/pnas.88.18.7958 Gonzalez, 1996, Use of transgenic animals in carcinogenesis studies, Mol. Carcinog., 16, 63, 10.1002/(SICI)1098-2744(199606)16:2<63::AID-MC1>3.0.CO;2-O Gorelick, 1996, A strategy for the application of transgenic rodent mutagenesis assays, Environ. Mol. Mutagen., 28, 434, 10.1002/(SICI)1098-2280(1996)28:4<434::AID-EM20>3.0.CO;2-F Heddle, 1996, Risk estimation from somatic mutation assays, Mutat. Res., 365, 107, 10.1016/S0165-1110(96)90015-9 Hakura, 1998, Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta™Mouse), Mutat. Res., 398, 123, 10.1016/S0027-5107(97)00248-0 Hakura, 1999, Multiple organ mutation in the lacZ transgenic mouse (Muta™Mouse) 6 months after oral treatment (5 days) with benzo[a]pyrene, Mutat. Res., 426, 71, 10.1016/S0027-5107(99)00046-9 Ushijima, 1994, Tissue-specific mutational spectra of 2-amino-3,4-dimethylimidazo[4,5-f]quinoline in the liver and bone marrow of lacI transgenic mice, Carcinogenesis, 15, 2805, 10.1093/carcin/15.12.2805 Okonogi, 1997, Agreement of mutational characteristics of heterocyclic amines in lacI of the Big Blue® mouse with those in tumor related genes in rodents, Carcinogenesis, 18, 745, 10.1093/carcin/18.4.745 Hakura, 1998, Toxicity profile of benzo[a]pyrene in the male lacZ transgenic mouse (MutaMouse) following oral administration for 5 consecutive days, Regul. Toxicol. Pharmacol., 27, 273, 10.1006/rtph.1998.1218 Mientjes, 1994, An improved selection method for λlacZ− phages based on galactose sensitivity, Transgenic Res., 3, 67, 10.1007/BF01976029 Mientjes, 1996, Comparison of the X-gal- and P-gal-based systems for screening of mutant λlacZ phages originating from the transgenic mouse strain 40.6, Mutat. Res., 360, 101, 10.1016/0165-1161(96)00004-0 1996, Organ variation in the mutagenicity of ethylnitrosourea in Muta™Mouse: results of the collaborative study on the transgenic mutation assay by JEMS/MMS, Environ. Mol. Mutagen., 28, 363, 10.1002/(SICI)1098-2280(1996)28:4<363::AID-EM10>3.0.CO;2-D Vijg, 1996, Bacteriophage lambda and plasmid lacZ transgenic mice for studying mutations in vivo, 391 Tsutsui, 1999, Sequence of the lacZ transgene of the Muta™Mouse, Environ. Mutagen Res., 21, 39 Nagao, 1998, No direct correlation between mutant frequencies and cancer incidence induced by MeIQ in various organs of Big Blue® mice, Mutat. Res., 400, 251, 10.1016/S0027-5107(98)00032-3 Kalnins, 1983, Sequence of the lacZ gene of Escherichia coli, EMBO J., 2, 593, 10.1002/j.1460-2075.1983.tb01468.x Douglas, 1994, Sequence spectra of spontaneous lacZ gene mutations in transgenic mouse somatic and germline tissues, Mutagenesis, 9, 451, 10.1093/mutage/9.5.451 de Boer, 1998, Spontaneous mutation in lacI transgenic mice: a comparison of tissues, Mutagenesis, 13, 109, 10.1093/mutage/13.2.109 Conney, 1982, Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons, Cancer Res., 42, 4875 Buening, 1978, Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene, Proc. Natl. Acad. Sci. U. S. A., 75, 5358, 10.1073/pnas.75.11.5358 Slaga, 1979, Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides, Cancer Res., 39, 67 Meehan, 1979, Double-stranded DNA stereoselectively binds benzo[a]pyrene diol epoxides, Nature, 277, 410, 10.1038/277410a0 Cheng, 1989, DNA adducts from carcinogenic and noncarcinogenic enantiomers of benzo[a]pyrene dihydrodiol epoxide, Chem. Res. Toxicol., 2, 334, 10.1021/tx00011a011 Ruggeri, 1993, Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene, Proc. Natl. Acad. Sci. U. S. A., 90, 1013, 10.1073/pnas.90.3.1013 Unfried, 1997, P53 mutations in tumours induced by intraperitoneal injection of crocidolite asbestos and benzo[a]pyrene in rats, Exp. Toxicol. Pathol., 49, 181, 10.1016/S0940-2993(97)80005-X Walker, 1996, Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice, Cancer Res., 56, 4654